medline.ch Onkologie Urologische Tumoren

	Navigating the landscape of targeted therapies for renal cell carcinoma in the era of precision medicine (Review). Mol Med Rep Cui H, Song J, Yang P, Zhang Z, Liu Y, Zhang G, Tian A, Che J, Liu Y, Sun H, Xu Y. PMID: 42885310 [PubMed - indexed for MEDLINE]
	Soy Consumption and the Risk of Developing Bladder Cancer: A Pooled Analysis of Cohort Studies from the International Pooled Bladder Cancer Epidemiology and Nutritional Determinants (BLEND) Study. Nutrients Wu YW, Yu EY, Chen YT, Li MH, Liang YT. PMID: 42884561 [PubMed - indexed for MEDLINE]
	Urinary DNA Methylation Profiling Identifies a Biologically Distinct Subgroup of Low-Grade Urothelial Carcinoma with High-Grade-Associated Features. Int J Mol Sci Andreu-Inglés M, Onoiu AI, Grifoll-Escoda M, Hernández-Aguilera A, Gumà-Padró J, Riu F, Peña K, Camps J, Parada D. PMID: 42884175 [PubMed - indexed for MEDLINE]
	Gut Microbiota Signatures Associated with Metastatic Prostatic Cancer Treated with Androgen Receptor Pathway Inhibitor (ARPI) Therapy. Int J Mol Sci Pérez-Castro S, Carballo-Quinta M, Rodríguez-Costas N, Freire-Rodríguez A, Davina-Nunez C, Bellas-Pereira A, Taboada-Rodríguez P, Pérez-Schoch M, Cabrera-Alvargonzález JJ, Muller-Arteaga CA, Sánchez-García JF, Cespón-Outeda E, López-Díez ME. PMID: 42883703 [PubMed - indexed for MEDLINE]
	The Enemy of My Enemy: Two Cases of De Novo Metastatic Small-Cell Neuroendocrine Prostate Cancer with BRCA2 Alterations and Brain Metastases. Int J Mol Sci Kjer MF, Poulsen MH, Kjær-Frifeldt S, Holt MI, Vilstrup MH, Zedan AH. PMID: 42883702 [PubMed - indexed for MEDLINE]
	Cytoreductive Radical Prostatectomy in Oligometastatic Prostate Cancer and the Role of the Robotic Platform: A Narrative Review. Cancers (Basel) Rivas JG, Silva PG, Silva HMFSD, Severo L, Pinheiro LC, Romo IG, Redondo-González E, González-Santander C, Sierra JM. PMID: 42882901 [PubMed]
	Consumption of Processed Meat and Unprocessed Red Meat and Risk of Bladder Cancer: A Pooled Analysis of 30 Cohort Studies. Cancers (Basel) Wang Z, Afshar N, Hodge AM, Jayasekara H, Koutros S, van den Brandt PA, Wolk A, Wang M, Hou T, Adami HO, Åkesson A, Arcan C, Bertrand KA, Bittoni M, Bogumil D, Cai H, Cross AJ, Eliassen AH, Freudenheim JL, Gierach GL, Giovannucci EL, Huang WY, Jakszyn P, Kanehara R, Kirsh VA, Koh WP, Kroenke CH, Lacey JV, Liao LM, Loftfield E, Ma C, Marchand LL, Martinez ME, Miller AB, Moore SC, Mucci LA, Munro HM, Neuhouser ML, Petrick JL, Poynter JN, Preston MA, Prizment A, Rees S, Robien K, Rohan TE, Sandin S, Sawada N, Schernhammer ES, Shams-White MM, Shrubsole MJ, Shu XO, Sinha R, Sieri S, Song M, Stampfer MJ, Stolzenberg-Solomon RZ, Triplette M, Um CY, Visvanathan K, VoPham T, Wang F, Wang R, Wang SS, Wang Y, Weiderpass E, Wilkens L, Willett WC, Yuan JM, Zheng W, Rothman N, Lynch BM, Silverman DT, Smith-Warner SA, Milne RL. PMID: 42882897 [PubMed]
	Metabolic Reprogramming in Bladder Cancer: Molecular Drivers, Immune Regulation and Therapeutic Opportunities. Cancers (Basel) Li S, Li M, Zhang Y, Pu J, Sun J, Li C, Guo C. PMID: 42882896 [PubMed]
	Treatment Sequencing in ARPI-Pre-Exposed Metastatic Castration-Resistant Prostate Cancer: Radioligand Therapy, PARP Inhibitors, and Antibody-Drug Conjugates. Cancers (Basel) Sharaf B, Al-Rwashdeh M, El Khatib O, Al-Ibraheem A, Abu Fara A, Ismail A, Alkasrawi H, Abdalla M, Jehad S. PMID: 42882814 [PubMed]
	Early Renal Effects After Radioactive Iodine Therapy in Differentiated Thyroid Cancer: A Prospective Observational Study. Diagnostics (Basel) Solako, Maman A, Lalo. PMID: 42882278 [PubMed]
	Institutional Variation in MRI Utilization After Prostatectomy for Prostate Cancer: A Multicenter Study. Healthcare (Basel) Lee S, Choi MH, Kim H, Chung DJ, Lee SL, Lim YS, Kim HA, Park G, Lee W. PMID: 42881570 [PubMed]
	Bladder cancer organoids in precision medicine: bridging basic science, clinical therapeutics and drug development. Cancer Cell Int Zhong X, Wang G, Zhang H, Shi Y, Xiong Z, Han J. PMID: 42881413 [PubMed]
	Beyond traditional nephrometry: a 3D quantitative framework for predicting pentafecta and evaluating mediation effects in nephron-sparing surgery. BMC Urol Li J, Zhang Z, Yang C, Lin R, Zhang C, Liao W, Wang K, Li S, Yao X. PMID: 42881392 [PubMed - indexed for MEDLINE]
	Combination therapy for BCG-unresponsive non-muscle-invasive bladder cancer: biological rationale and ongoing clinical strategies. Nat Rev Urol Daneshmand S, Boorjian SA, Meeks JJ, Lotan Y, Kassouf W, Kulkarni GS, Gontero P, Albers P, Jakobsen JS, Juul K. PMID: 42881230 [PubMed - as supplied by publisher]
	Prostate Cancer Incidence and Disease Characteristics in Transgender Women Receiving Gender-affirming Hormone Therapy: A Systematic Review with Meta-analysis. Eur Urol Oncol Oberoi K, Trevaskis I, Hassan S, Sethi K. PMID: 42881114 [PubMed - as supplied by publisher]
	Perioperative enfortumab vedotin-pembrolizumab, gemcitabine-cisplatin-durvalumab, and dose-dense MVAC in cisplatin-eligible muscle-invasive bladder cancer: A benefit-risk Bayesian network meta-analysis. Urol Oncol Subiela JD, González-Padilla DA, Scilipoti P, Slusarczyk A, Pichler R, Guerrero-Ramos F, Artiles-Medina A, Caño-Velasco J, Aumatell J, Krajewski W, Mertens LS, Teoh JY, Contieri R, Maiorano BA, Claps F, Del Giudice F, D'Andrea D, Gajate P, Guerrero P, Gallioli A, Villacampa F, Acosta EA, Lozano F, Carrion A, Afferi L, Crespo L, Marcq G, Soria F, Moschini M, Grobet-Jeandin E, Albisinni S, Alvarez-Maestro M, San-José Manso L, Gomez Dos Santos V, Roupret M, Burgos Revilla FJ, Pradere B, Buisan O, Young Academic Urologist (YAU) Urothelial Carcinoma Working Group. PMID: 42881094 [PubMed - as supplied by publisher]
	Feasibility of Laparoscopic Partial Cystectomy for Bladder Paraganglioma: A Four-Case Series. Asian J Endosc Surg Sato T, Hayata N, Miura T, Mishina M, Kitamura T, Tsuiki M, Hijikata Y, Kuwahara R, Kasahara S, Moriyoshi K, Kanno T. PMID: 42880937 [PubMed - indexed for MEDLINE]
	Intrapancreatic Fat Deposition and Prostate Cancer Risk: A Primary Case-Control Study. Technol Cancer Res Treat Wang H, Li H, Zhang K, Wu L, Wang C, Fang D, Yu Y, Yang X, Sun S, Chen X, Bi S, Wen H. PMID: 42880771 [PubMed - indexed for MEDLINE]
	Diet quality and prognosis in patients with non-muscle invasive bladder cancer: the Be-Well Study. Urology Ergas IJ, Zimbalist A, Haque R, Lee VS, Roh JM, Cannavale KL, Wang Z, Loo RK, Aaronson DS, Quesenberry CP Jr, Kushi LH, Tang L, Kwan ML. PMID: 42880421 [PubMed - as supplied by publisher]
	Diagnostic performance of post-chemoradiotherapy nacVI-RADS for identifying pathological complete response in muscle-invasive bladder cancer. Eur J Radiol Fukui K, Kobayashi M, Yoshida S, Arita Y, Yamagiwa K, Tsuchiya J, Fujiwara M, Aslan S, Tasdemir MN, Fujii Y, Tateishi U. PMID: 42880152 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 182219

Seite 1 von 9111

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung